Overview

Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056

Status:
Withdrawn
Trial end date:
2022-01-03
Target enrollment:
Participant gender:
Summary
This is a study to assess safety, tolerability and interactions of AFQ056 and cocaine in patients with cocaine use disorder.
Phase:
Phase 1
Details
Lead Sponsor:
Novartis Pharmaceuticals
Collaborator:
National Institute on Drug Abuse (NIDA)